There are 2789 resources available
1838P - Germline mutations in homologous recombination repair (HRR) pathway in a Chinese multi-cancer retrospective analysis
Presenter: Linlin Zhang
Session: ePoster Display
1839P - Infectious complications post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A meta-analysis
Presenter: Akhil Jain
Session: ePoster Display
1774P - Exploration of torque teno virus (TTV) levels as marker for immune suppression during systemic therapy in advanced solid cancer patients
Presenter: Angelika M. Starzer
Session: ePoster Display
1841P - Retrospective review of frailty in lung cancer patients
Presenter: Meera Chauhan
Session: ePoster Display
1842P - Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
Presenter: Tina Lamy
Session: ePoster Display
1707P - A single G-CSF administration is enough to limit neutropenia in patients treated by eribulin
Presenter: Antonin Schmitt
Session: ePoster Display
1708P - Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)
Presenter: Ramon Mohanlal
Session: ePoster Display
1709P - Prediction of febrile neutropenia (FN), hospitalization (Hosp) rates, and infection (Inf) rates in chemotherapy-induced neutropenia (CIN) patients (pts) treated with the plinabulin and pegfilgrastim combination (Plin+Peg) using a meta-analysis (MA)-based tool
Presenter: Stephan Ogenstad
Session: ePoster Display
1710P - Impact of adding plinabulin to pegfilgrastim for the prevention of chemotherapy induced neutropenia (CIN) on patient quality of life (QoL)
Presenter: Douglas Blayney
Session: ePoster Display
1711P - Real-world study of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal tumors
Presenter: Nong Xu
Session: ePoster Display